Publication | Closed Access

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

Hematological MalignancyLymphoid NeoplasiaMedicineMalignant Blood DisorderHigh LevelHematologyImmunologyCell DeathPathologyAdult T-cell Leukemia-lymphomaOncologyCancer Research